Improvement of antioxidative activity of resveratrol by elongating conjugated chain: A DFT theoretical study

Computational and Theoretical Chemistry

Volumn 1019, Issue 1, 2013, Pages 39-47

  Lu, Lilin ^a   Zhu, Shufang ^a   Zhang, Haijun ^a   Zhang, Shaowei ^a  

^a WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Analogs; Antioxidative activity; DFT; Resveratrol

Indexed keywords

EID: 84880737866     PISSN: 2210271X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comptc.2013.06.019     Document Type: Article

References (49)

1. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: thein vivoevidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
2. Gehm B.D., McAndrews J.M., Chien P.-Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 1997, 94:14138-14143.
3. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., Fong H.H.S., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
4. Klinge C.M., Wickramasinghe N.S., Ivanova M.M., Dougherty S.M. Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J. 2008, 22:2185-2197.
5. Kundu J.K., Surh Y.-J. Cancerchemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 2008, 269:243-261.
6. Bishayee A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev. Res. 2009, 2:409-418.
7. Ruweler M., Gulden M., Maser E., Murias M., Seibert H. Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro. Chem. -Biol. Interact. 2009, 182:128-135.
8. Robb E.L., Winkelmolen L., Visanji N., Brotchie J., Stuart J.A. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem. Biophys. Res. Commun. 2008, 372:254-259.
9. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 2000, 59:865-870.
10. Bass T.M., Weinkove D., Houthoofd K., Gems D., Partridge L. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech. Ageing Dev. 2007, 128:546-552.
11. Kumar A., Kaundal R.K., Iyer S., Sharma S.S. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 2007, 80:1236-1244.
12. Zhang H., Shih A., Rinna A., Forman H.J. Exacerbation of tobacco smoke mediated apoptosis by resveratrol: an unexpected consequence of its antioxidant action. Int. J. Biochem. Cell Biol. 2011, 43:1059-1064.
13. Mukherjee S., Lekli I., Gurusamy N., Bertelli A.A.A., Das D.K. RETRACTED: expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radical Biol. Med. 2009, 46:573-578.
14. Chen W.P., Su M.J., Hung L.M. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. Eur. J. Pharmacol. 2007, 554:196-204.
15. Dani C., Bonatto D., Salvador M., Pereira M.D., Henriques J.A.P., Eleutherio E. Antioxidant protection of resveratrol and catechin in Saccharomyces cerevisiae. J. Agric. Food Chem. 2008, 56:4268-4272.
16. Rivera L., Moron R., Zarzuelo A., Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem. Pharmacol. 2009, 77:1053-1063.
17. Yoon D.-H., Kwon O.-Y., Mang J.Y., Jung M.J., Kim D.Y., Park Y.K., Heo T.-H., Kim S.-J. Protective potential of resveratrol against oxidative stress and apoptosis in Batten disease lymphoblast cells. Biochem. Biophys. Res. Commun. 2011, 414:49-52.
18. Pearson K.J., Baur J.A., Lewis K.N., Peshkin L., Price N.L., Labinskyy N., Swindell W.R., Kamara D., Minor R.K., Perez E., Jamieson H.A., Zhang Y., Dunn S.R., Sharma K., Pleshko N., Woollett L.A., Csiszar A., Ikeno Y., Couteur D.L., Elliott P.J., Becker K.G., Navas P., Ingram D.K., Wolf N.S., Ungvari Z., Sinclair D.A., de Cabo R. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008, 8:157-168.
19. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006, 127:1109-1122.
20. Valenzano D.R., Terzibasi E., Genade T., Cattaneo A., Domenici L., Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 2006, 16:296-300.
21. Rubiolo J.A., Mithieux G., Vega F.V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 2008, 591:66-72.
22. Dasgupta B., Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. USA 2007, 104:7217-7222.
23. Saiko P., Szakmary A., Jaeger W., Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat. Res. 2008, 658:68-94.
24. Berrougui H., Grenier G., Loued S., Drouin G., Khalil A. A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux. Atherosclerosis 2009, 207:420-427.
25. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 1993, 24:1103-1104.
26. Kaindl U., Eyberg I., Rohr-Udilova N., Heinzle C., Marian B. The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage. Food Chem. Toxicol. 2008, 46:1320-1326.
27. Ndiaye M., Philippe C., Mukhtar H., Ahmad N. The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges. Arch. Biochem. Biophys. 2011, 508:164-170.
28. Udenigwe C.C., Ramprasath V.R., Aluko R.E., Jones P.J. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr. Rev. 2008, 66:445-454.
29. Fang J.G., Lu M., Chen Z.H., Zhu H.H., Li Y., Yang L., Wu L.M., Liu Z.L. Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Chem. Eur. J. 2002, 8:4191-4198.
30. Stivala L.A., Savio M., Carafoli F., Perucca P., Bianchi L., Maga G., Forti L., Pagnoni U.M., Albini A., Prosperi E., Vannini V. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem. 2001, 276:22586-22594.
31. Iacopini P., Baldi M., Storchi P., Sebastiani L. Catechin, epicatechin, quercetin, rutin and resveratrol in red grape: content, in vitro antioxidant activity and interactions. J. Food Compos. Anal. 2008, 21:589-598.
32. Fabris S., Momo F., Ravagnan G., Stevanato R. Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes. Biophys. Chem. 2008, 135:76-83.
33. Fan G.J., Liu X.D., Qian Y.P., Shang Y.J., Li X.Z., Dai F., Fang J.G., Jin X.L., Zhou B. 4,4'-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced antioxidant activity and cytotoxicity. Bioorg. Med. Chem. 2009, 17:2360-2365.
34. Cao H., Pan X., Li C., Zhou C., Deng F., Li T. Density functional theory calculations for resveratrol. Bioorg. Med. Chem. Lett. 2003, 13:1869-1871.
35. Queiroz A.N., Gomes B.A.Q., Moraes W.M., Borges R.S. A theoretical antioxidant pharmacophore for resveratrol. Eur. J. Med. Chem. 2009, 44:1644-1649.
36. Mikulski D., Gorniak R., Molski M. A theoretical study of the structure-radical scavenging activity of trans-resveratrol analogues and cis-resveratrol in gas phase and water environment. Eur. J. Med. Chem. 2010, 45:1015-1027.
37. Shang Y.J., Qian Y.P., Liu X.D., Dai F., Shang X.L., Jia W.Q., Liu Q., Fang J.G., Zhou B. Radical-scavenging activity and mechanism of resveratrol-oriented analogues: influence of the solvent, radical, and substitution. J. Org. Chem. 2009, 74:5025-5031.
38. Fang J.G., Zhou B. Structure-activity relationship and mechanism of the tocopherol-regenerating activity of resveratrol and its analogues. J. Agric. Food Chem. 2008, 56:11458-11463.
39. Mikstacka R., Rimando A.M., Ignatowicz E. Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro. Plant Foods Hum. Nutr. 2010, 65:57-63.
40. Mikulski D., Molski M. Quantitative structure-antioxidant activity relationship of trans-resveratrol oligomers, trans-4,4'-dihydroxystilbene dimer, trans-resveratrol-3-O-glucuronide, glucosides: Trans-piceid, cis-piceid, trans-astringin and trans-resveratrol-4'-O-β-D-glucopyranoside. Eur. J. Med. Chem. 2010, 45:2366-2380.
41. Tang J.J., Fan G.J., Dai F., Ding D.J., Wang Q., Lu D.L., Li R.R., Li X.Z., Hu L.M., Jin X.L., Zhou B. Finding more active antioxidants and cancer chemoprevention agents by elongating the conjugated links of resveratrol. Free Radic. Biol. Med. 2011, 50:1447-1457.
42. Wright J.S., Johnson E.R., DiLabio G.A. Predicting the activity of phenolic antioxidants: theoretical method, analysis of substituent effects, and application to major families of antioxidants. J. Am. Chem. Soc. 2001, 123:1173-1183.
43. M.J. Frisch, et al. Gaussian 03, Revision B.05, Gaussian, Inc., Pittsburgh PA, 2003.
44. Stojanović S., Brede O. Elementary reactions of the antioxidant action of trans-stilbene derivatives: resveratrol, pinosylvin and 4-hydroxystilbene. Phys. Chem. Chem. Phys. 2002, 4:757-764.
45. Stojanović S., Sprinz H., Brede O. Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation. Arch. Biochem. Biophys. 2001, 391:79-89.
46. Parkinson C.J., Mayer P.M., Radom L. An assessment of theoretical procedures for the calculation of reliable radical stabilization energies. J. Chem. Soc. Perkin Trans. 1999, 2(11):2305-2313.
47. Litwinienko G., Ingold K.U. Solvent effects on the rates and mechanisms of reaction of phenols with free radicals. Acc. Chem. Res. 2007, 40:222-230.
48. Caruso F., Tanski J., Villegas-Estrada A., Rossi M.J. Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. Agric. Food Chem. 2004, 52:7279-7285.
49. Sirk T.W., Brown E.F., Sum A.K., Friedman M. Molecular dynamics study on the biophysical interactions of seven green tea catechins with lipid bilayers of cell membranes. J. Agric. Food Chem. 2008, 56:7750-7758.